ADTRALZA 300 mg/2 mL sol inj 300 mg 2x2 ml

7680702770017 CH-70277 D11AH07 07.15.0.

Active substances:

Tralokinumabum

No images available

Details

Product number
7027701
CPT
-
Packaging group
2 x 2
Unit
ml
Composition
tralokinumabum 300 mg, natrii acetas trihydricus, acidum aceticum glaciale, natrii chloridum, polysorbatum 80, aqua ad iniectabile, ad solutionem pro 2 ml corresp. natrium 5.954 mg.

Articles (1)

Adtralza 300 mg/2 mL, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
2 x 2
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/09/2026
Patient information leaflet
Français
18/09/2026
Patient information leaflet
Italien
18/09/2026

Detailed composition

Substance Quantity Type Category
tralokinumabum
300.0 MG Substance Wirkstoff (Principe actif)
natrii acetas trihydricus
- Substance HNIDK
acidum aceticum glaciale
- Substance HNIDK
natrii chloridum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
5.954 MG Substance HBESI

Reimbursement information

Public price
CHF 1051.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2026

Authorization holder

Leo Pharmaceutical Products Sarath Ltd.

8302 Kloten

Authorization information

Swissmedic authorization number
70277
Drug name
Adtralza, Injektionslösung im Fertigpen
Galenic form
INLFP
ATC Code
D11AH07
Authorization status
Z
Dispensation category
B
First authorization
05/02/2026
Authorization expiration date
04/02/2031
IT number
07.15.0.
Domain
Human medicine
Field of application
Behandlung erwachsener Patienten mit mittelschwerer bis schwerer atopischer Dermatitis (AD)

Packaging details

Description (FR)
ADTRALZA 300 mg/2 mL sol inj 300 mg 2x2 ml
Description (DE)
ADTRALZA 300 mg/2 mL Inj Lös 300 mg 2x2 ml
Market launch
01/06/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data